ArticleACS omega2025
Postprandial Glucose Reduction by Pomelo Albedo Treated with β‑Cyclodextrin and Ultrasound.
Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bitter Compounds in Medicinal Food Plants Based on Traditional Chinese Medicine: Analysis and Regulation Strategies from Chemical Structure to Perception Mechanisms.Molecules (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study evaluated the use of β-cyclodextrin combined with ultrasound-assisted processing (UAP) to reduce bitterness in pomelo albedo and assess its potential to lower postprandial blood glucose. β-Cyclodextrin was applied at concentrations ranging from 0.0 to 0.9% weight per volume, with and without ultrasonication. The combination of 0.7% β-cyclodextrin and ultrasound significantly achieved the greatest reductions in naringin and limonin by 57.55% and 65.74%, respectively. Sensory analysis confirmed a significant 80.56% decrease in perceived bitterness without adverse effects on the texture. Treated samples showed a higher water absorption index (9.02 ± 0.47 compared to 5.71 ± 0.40 in the control) and greater viscosity (341 ± 1.99 compared to 259 ± 3.10 cP), without altering the total dietary fiber content. In a randomized crossover trial involving 15 participants, consumption of 5 g of treated pomelo albedo with 52 g of available carbohydrate reduced the peak blood glucose concentration (
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.